Safety and Tolerability Trial of Psilocybin in Healthy Older Adults
Safety and Tolerability Trial of Psilocybin in Healthy Older Adults
Recruiting · NCT07516405 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Tolerability Trial of Psilocybin in Healthy Older Adults | Healthy Volunteer; Older Adults (65-85 Years) | Recruiting | Phase 1 | 2026-09-16 | NCT07516405 |
7 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dana-Farber Cancer Institute | 324 |
| Emory University | 393 |
| National Institute on Aging (NIA) | 571 |
| NYU Langone Health | 359 |
| University of California, San Francisco | 637 |
| University of Colorado, Denver | 475 |
| University of Nebraska | 106 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana-Farber Cancer Institute | Boston | United States | 626 |
| Emory University Brain Health Center | Atlanta | United States | 2 |
| New York University Langone Health, Center for Psychedelic Medicine | New York | United States | 1 |
| University of California San Francisco (UCSF) Department of Neurology | San Francisco | United States | 1 |
| University of Colorado Anschutz Medical Campus | Aurora | United States | 142 |
| University of Nebraska Medical Center | Omaha | United States | 12 |